Rheaplant
United States, Oakland, California
About Rheaplant
Rheaplant is a San Francisco-based startup, founded in 2025, that produces high-value botanical and nutraceutical ingredients through plant cell culture instead of field-grown crops. It grows plant cells in modular bioreactors under controlled conditions, betting on a food-grade, scale-out approach to reach unit economics that conventional biopharma-grade systems cannot. The company sells primarily B2B to food, supplement and nutrition makers seeking consistent, year-round supply of compounds such as ashwagandha, rhodiola and ginseng.
Latest Funding
SeedAnnounced 2026-05-18
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
3 signals · where the capital is going
Building out a distributed, modular bioreactor approach (2,000-5,000L modules) with a stated goal of 50,000L+ total food-grade capacity within about six years t…
agfundernews.com
+2 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to Rheaplant? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Rheaplant.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Rheaplant, and who are their main competitors?
Sign up free to ask AI about Rheaplant
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Big Idea Ventures
Lead investor · Seed
Tech Stack
Key Highlights
AI InsightsSelected into Big Idea Ventures' Global Food Innovation Fund II (GFIF II) Cohort 4, which carries a standard $200K investment package plus access to the fund's mentor, R&D and corporate-partner network.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Rheaplant
Selling to Rheaplant? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Rheaplant.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.